Lenvat 4 Capsule
By Lenvat
Rx
30 Capsule in a Bottle

Composition
Lenvatinib(4mg)

Manufacturer - Natco Pharma Ltd
Natco House, Road No.2, Banjara Hills, Hyderabad-500 034, India

Expires on or after
May, 2026

liver
When using Lenvat 4 Capsule, it is important to be cautious if you have liver disease. Patients with liver conditions may require adjustments in the dosage of Lenvat 4 Capsule. It is advisable to seek guidance from your doctor before using this medication to ensure safety and effectiveness.

kidney
Lenvat 4 Capsule requires caution in patients with kidney disease. Dosage adjustment may be necessary; consult your doctor before use.

alcohol
Consult your doctor when consuming alcohol with Lenvat 4 Capsule.

driving
The effects of driving while taking Lenvat 4 Capsule are unknown. Refrain from driving if you notice any symptoms that impact your focus or reaction time.

pregnancy
Lenvat 4 Capsule may not be safe to use during pregnancy. Animal studies show harmful effects on the baby. Your doctor will consider the risks and benefits before prescribing. Please consult your doctor.

breastfeeding
Caution is advised when breastfeeding while using Lenvat 4 Capsule as it may be unsafe. Limited human data indicates potential harm to the baby through passage of the drug into breastmilk.
Habit Forming | No |
Chemical Class | Quinoline Carboxamides |
Therapeutic Class | - |
Action Class | Tyrosine kinase inhibitors |
₹3000
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024